Loading Shopping Cart Items...
FREE FOR MEMBERS!
Description: Heparin Induced Thrombocytopenia (HIT) is an unintended, life-threatening consequence of heparin administration. It is an autoimmune disorder that occurs in up to 8% of patients receiving heparin and heparin derivatives. The formation of HIT antibodies creates a paradoxical situation in which patients receiving a known anticoagulant medication experience thrombotic episodes in conjunction with a sudden drop in platelet count. This presentation will outline the clinical symptoms and underlying mechanisms responsible for the onset of this very serious clinical conundrum.
Start Date: Upon registration
Completion: Up to 52 weeks
At the end of this webinar you will be able to:
Speaker: Terence Litavec, MLT
Terence Litavec has worked as a medical laboratory technologist since 2004 and has served as the MLT Director of the BCSLS. He currently works in the Hematology Department at LifeLabs in Burnaby. Before that, he worked at Burnaby Hospital and Kelowna General Hospital, as well as Tacoma General Hospital and PhenoPath Laboratories, both in Washington State. He is certified by both the CSMLS and the ASCP. He is a certified specialist in hematology and coagulation, and he also has bench experience working in immunohistochemistry, flow cytometry, transfusion services, and some molecular methods such as FISH and PCR. He has always had a passion for teaching, and he has written and presented numerous educational lectures throughout Canada.
Recorded: May 26, 2018
PEP hours: 1
CPS credits: 0
*Note: PEP hours and/or CPS credits will only be awarded upon successful completion of the quiz.
Learner Feedback
"I [was looking for] a basic understanding of the causes and effects of this disease. This webinar presented this material so I could easily understand them."
"This is becoming more prevalent so I think it is important to understand the cause and the diagnostic testing of this very serious condition as more heparin therapy occurs."
Loading Shopping Cart Items...